Reversible posterior leucoencephalopathy during oral treatment with methotrexate

Journal of Neurology

Volumn 251, Issue 2, 2004, Pages 226-228

  Renard, Dimitri ^a   Westhovens, Rene ^a   Vandenbussche, Erik ^a   Vandenberghe, Rik ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BROMAZEPAM; DIPYRIDAMOLE; FOLIC ACID ANTAGONIST; LEVOTHYROXINE; METHOTREXATE; OMEPRAZOLE; PROPAMIDINE; PROPRANOLOL;

ADOLESCENT; ANAMNESIS; CASE REPORT; CEREBROVASCULAR DISEASE; CHRONIC DRUG ADMINISTRATION; CLINICAL FEATURE; DIAGNOSTIC TEST; DRUG USE; DRUG WITHDRAWAL; FEMALE; HASHIMOTO DISEASE; HUMAN; LABORATORY TEST; LETTER; LEUKOENCEPHALOPATHY; LOW DRUG DOSE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSORIATIC ARTHRITIS;

ALEXIA, PURE; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MEMORY DISORDERS; METHOTREXATE; MIDDLE AGED; NEUROTOXICITY SYNDROMES; OCCIPITAL LOBE; PERCEPTUAL DISORDERS; RECOVERY OF FUNCTION; VISION DISORDERS; VISUAL PERCEPTION;

EID: 1242337423     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-004-0287-5     Document Type: Letter

References (12)

1. rd revision. Modern Curriculum Press, Cleveland
2. Gijtenbeek JMM, van den Bent MJ, Vecht ChJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246:339-346
3. Lövblad KO, Kelkar P, Ozdoba C et al. (1998) Pure methotrexate encephalopathy presenting with seizures: CT and MRI features. Pediatr Radiol 28:86-91
4. Mahoney D, Shuster J, Nitschke R (1998) Acute Neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy - A pediatric oncology group study. J Clin Oncol 16:1712-1722
5. Riddoch JM (1993) Birmingham Object Recognition Battery (BORB). Lawrence Erlbaum Associates, Hove, UK
6. Strand V, Cohen S, Schiff M et al. (1999) Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 159:2542-2550
7. Worthley SG, McNeil JD (1995) Leukoencephalopathy in a patient taking low dose oral methotrexate therapy for rheumatoid arthritis. J Rheumatol 22:335-337
8. Beorlegui B, Aldaz A et al. (2000) Potential interaction between methotrexate and omeprazole. Ann Pharmacother 34:1024-1027
9. Coley SC, Porter DA, Calamante F, Chong WK, Connelly A (1999) Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity. Am J Neuroradiol 20:1507-1510
10. Provenzale JM, Petrella JR et al. (2001) Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. Am J Neuroradiol 22:1455-1461
11. Schwartz RB, Mulkern RV et al. (1998) Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. Am J Neuroradiol 19: 859-862
12. Mukherjee P, McKinstry RC (2001) Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 219:756-765